NCT00752596View on ClinicalTrials.gov

Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Congestive Heart Failure
Interventions
DRUG

Azimilide 2HCl

One tablet of 125 mg/day azimilide 2HCl, taken until the study is terminated

Trial Locations (1)

85251

Research Site, Scottsdale

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY